Intranasal Drug Delivery Devices Market Study Explores Industry Growth Toward $99.11 Billion

The Business Research Company’s Intranasal Drug Delivery Devices Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035

LONDON, GREATER LONDON, UNITED KINGDOM, August 12, 2026 /EINPresswire.com/ — “Intranasal drug delivery devices are becoming increasingly important in the pharmaceutical landscape due to their ability to deliver medications efficiently and non-invasively. As healthcare continues to evolve, these devices are gaining traction for treating various conditions, particularly respiratory and neurological disorders. Let’s explore the current market outlook, growth drivers, and regional dynamics shaping this sector.

Market Size and Growth Prospects for Intranasal Drug Delivery Devices
The market for intranasal drug delivery devices has seen significant growth in recent years. It is projected to expand from $65.09 billion in 2025 to $70.77 billion by 2026, reflecting a healthy compound annual growth rate (CAGR) of 8.7%. This upward trend in the past can be linked to a rise in respiratory and nasal disorders, the increasing preference for nasal routes for systemic drug delivery, growth in self-administration devices, approvals of new intranasal therapies, and the rise of outpatient treatment models.

Download a free sample of the intranasal drug delivery devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Looking ahead, the market is expected to maintain its strong momentum, reaching $99.11 billion by 2030 at a CAGR of 8.8%. Key factors driving this forecast include growth in biologics and vaccine development via nasal delivery, greater demand for homecare drug administration, expansion of intranasal applications for neurological treatments, increased investment in sophisticated drug-device combinations, and enhanced focus on patient adherence solutions. Emerging trends highlight the adoption of precision nasal delivery systems, a rising preference for non-invasive administration, development of multi-dose devices, expansion of patient-friendly delivery formats, and improvements targeting rapid drug absorption.

Understanding Intranasal Drug Delivery Devices
Intranasal drug delivery devices are specialized tools designed to administer medication directly into the nasal cavity. This area is highly vascularized and offers an extensive surface area, allowing for quick absorption of therapeutic agents into the bloodstream. These devices can deliver medications in forms such as sprays, powders, or liquid solutions, making them versatile for various treatments.

View the full intranasal drug delivery devices market report:
https://www.thebusinessresearchcompany.com/report/intranasal-drug-delivery-devices-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Aug_PR

Rising Chronic Disease Rates Fueling Market Demand
One of the primary drivers behind the increasing demand for intranasal drug delivery devices is the growing prevalence of chronic diseases. These conditions typically last a year or more, requiring ongoing medical care and often limiting daily activities. Intranasal devices provide a practical, non-invasive method for delivering medications directly where needed, promoting ease of use and fast absorption. For example, in June 2024, the National Health Service in the UK reported that the number of people at risk for type 2 diabetes in England rose to 3,615,330 in 2023, up from 3,066,330 in 2022. Additionally, there were 549,000 more individuals identified with pre-diabetes conditions like non-diabetic hyperglycemia. This increasing prevalence of chronic illnesses is significantly driving growth in this device market.

North America’s Leading Position in Global Intranasal Drug Delivery Devices Market
In 2025, North America held the largest market share for intranasal drug delivery devices. The report also covers other important regions such as Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, offering insights into the global distribution and regional growth patterns within this market.

What’s included in our 2026 market reports:

• Market attractiveness scoring and analysis
• Total addressable market (TAM) analysis
• Company scoring matrix graphics and tables
• Excel-based forecasting dashboards
• Market hotspots infographics
• Key technologies and future trend analysis
• Updated graphics and tables

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info

The Business Research Company – www.thebusinessresearchcompany.com

Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company

Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery